|
| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Hematology
|
2012
|
NHLBI
|
2T32HL086345-06
|
|
Training in Developmental Hematology
|
KOHN, DONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$245,488
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL088476-04
|
|
PHARMACOMECHANICAL CATHETER-DIRECTED THROMBOLYSIS FOR ACUTE DVT - ATTRACT TRIAL
|
VEDANTHAM, SURESH
|
WASHINGTON UNIVERSITY
|
MO
|
$1,373,888
|
|
Hematology
|
2012
|
NCI
|
4R37CA072614-16
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
SHANNON, KEVIN
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$320,588
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL090765-04
|
|
HSC transduction in situ by cellular delivery of integrating viral vectors
|
KURRE, PETER
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$477,797
|
|
Hematology
|
2012
|
NHLBI
|
7K23HL089217-04
|
|
Treatment of sickle cell acute pain episodes with intravenous gammagblobulin
|
SHI, PATRICIA
|
NEW YORK BLOOD CENTER
|
NY
|
$126,179
|
|
Hematology
|
2012
|
NIAMS
|
5R01AR043727-13
|
|
Hopkins Lupus Cohort
|
PETRI, MICHELLE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$641,036
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL098110-03
|
|
Clinical Implications of Pain Phenotypes in Sickle Cell Disease
|
HAYTHORNTHWAITE, JENNIFER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$460,273
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072028-10
|
|
Transfusion Medicine/Hemostasis Clinical Research Network
|
STRAUSS, RONALD
|
UNIVERSITY OF IOWA
|
IA
|
$164,063
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072072-10
|
|
Clinical Trials in Transfusion Medicine and Hemostasis
|
MCCULLOUGH, JEFFREY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$163,516
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072191-10
|
|
JHMI Core Clinical Center for TMHCTN
|
NESS, PAUL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$137,813
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072289-10
|
|
Transfusion Medicine/Hemostasis Core Clinical Center
|
ORTEL, THOMAS
|
DUKE UNIVERSITY
|
NC
|
$170,625
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072305-10
|
|
TRANSFUSION MEDICINE/HEMOSTASIS TRAIL SITE AT PSBC
|
SLICHTER, SHERRILL
|
PUGET SOUND BLOOD CENTER
|
WA
|
$204,531
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072331-10
|
|
Transfusion Medicine/Hemostasis Clinical Research Network
|
TRIULZI, DARRELL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$162,422
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072355-10
|
|
Transfusion Medicine/Hemostasis Clinical Trials Network
|
KEY, NIGEL
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$159,688
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072359-08
|
|
Reducing Mortality from Acute Hemorrhage in Trauma
|
HESS, JOHN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$82,688
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072196-10
|
|
Novel Therapies in Hemostasis and Transfusion
|
BUSSEL, JAMES
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$183,750
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072290-10
|
|
TMH Clinical Trials Network-Wisconsin Core Clinical Center
|
MC FARLAND, JANICE
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$195,370
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072346-10
|
|
Transfusion/Hemostasis clinical research network
|
SACHAIS, BRUCE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$172,266
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072283-10
|
|
Oklahoma-UT Southwestern Hemostasis Consortium
|
GEORGE, JAMES
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$160,234
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072299-08
|
|
MGH Transfusion Medicine and Hemostasis Network Clinical Core Center
|
KUTER, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$82,688
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072033-08
|
|
Transfusion Medicine/Hemostasis Clinical Research Network
|
MCCRAE, KEITH
|
THE CLEVELAND CLINC FOUNDATION
|
OH
|
$28,260
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072274-10
|
|
Hemostasis Clinical Research Network Protocols
|
LEISSINGER, CINDY
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$15,782
|
|
Hematology
|
2012
|
NHLBI
|
5U01HL072268-10
|
|
Transfusion Medicine/Hemostasis Clinical Trials Network-Data Coordinating Center
|
ASSMANN, SUSAN
|
NEW ENGLAND RESEARCH INSTITUTES, INC.
|
MA
|
$3,426,792
|
|
Hematology
|
2012
|
NHLBI
|
4R01HL088511-03
|
|
Respect, Trust, and Patient Outcomes in Sickle Cell Disease
|
BEACH, MARY CATHERINE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$729,985
|
|
Hematology
|
2012
|
OD
|
1G20OD016081-01
|
|
Installation of Energy-Efficient Cage Washers for Childrens Hospital Vivarium
|
JOHNSON, PHILIP
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
PA
|
$500,000
|
|
Hematology
|
2012
|
NCI
|
5R01CA139872-03
|
|
Synstatin Therapy for Multiple Myeloma
|
RAPRAEGER, ALAN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$389,053
|
|
Hematology
|
2012
|
NCI
|
4R01CA138402-03
|
|
Targeting surface b2M for myeloma and bone therapy
|
YI, QING
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$316,448
|
|
Hematology
|
2012
|
NCI
|
2P50CA094056-12
|
7928
|
PET Imaging of GVHD and GVL after treatment with Azacitidine
|
PIWNICA-WORMS, DAVID
|
WASHINGTON UNIVERSITY
|
MO
|
$114,699
|
|
Hematology
|
2012
|
NCI
|
5R01CA093897-09
|
|
Myeloma-Microenvironment Interaction Dynamics
|
YACCOBY, SHMUEL
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$257,868
|
|
Hematology
|
2012
|
NCI
|
5R01CA105129-07
|
|
Regulation of hematopoietic stem cell differentiation
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$299,591
|
|
Hematology
|
2012
|
NCI
|
5R01CA056876-19
|
|
Hoxa9, Meis1, and Pbx in Self-renewal and Leukemogenesis
|
KAMPS, MARK
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$365,531
|
|
Hematology
|
2012
|
NCI
|
5R01CA096735-10
|
|
t(8;21) and SON in Blood Cell Proliferation and Differentiation
|
ZHANG, DONG-ER
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$358,571
|
|
Hematology
|
2012
|
NCI
|
5R01CA083962-13
|
|
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
MO
|
$391,427
|
|
Hematology
|
2012
|
NIEHS
|
5R01ES004862-18
|
|
Ah Receptor Dysregulation Alters Hematopoietic Stem Cells
|
GASIEWICZ, THOMAS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$370,868
|
|
Hematology
|
2012
|
NCI
|
5R01CA064140-19
|
|
Role of AML1-ETO in Acute Leukemia
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY MED CTR
|
TN
|
$307,553
|
|
Hematology
|
2012
|
NCI
|
5R01CA140806-03
|
|
Proteomic biomarkers of ALK+ lymphoma
|
LIM, MEGAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$310,970
|
|
Hematology
|
2012
|
NCI
|
5R01CA077429-13
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
TESTA, JOSEPH
|
FOX CHASE CANCER CENTER
|
PA
|
$410,451
|
|
Hematology
|
2012
|
NIAID
|
5R37AI021256-27
|
|
Immunobiology of B Cell Differentiation
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$368,200
|
|
Hematology
|
2012
|
NCI
|
5R01CA089341-09
|
|
Functional Characterization of MLL Gene Fusions
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
OH
|
$278,052
|
|
Hematology
|
2012
|
NCI
|
5R01CA127910-06
|
|
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
GA
|
$311,976
|
|
Hematology
|
2012
|
NCI
|
5R01CA050947-20
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$278,781
|
|
Hematology
|
2012
|
NICHD
|
5R01HD058005-04
|
|
Pathways of Maternal Anemia
|
OLEINIKOV, ANDREW
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$562,997
|
|
Hematology
|
2012
|
NCI
|
5R01CA138891-03
|
|
In vivo targeting of hematopoetic cells with glycan ligands of siglecs
|
PAULSON, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$379,941
|
|
Hematology
|
2012
|
NCI
|
5R01CA062275-17
|
|
Retinoic Acid Paradox and Promyelocitic Leukemia
|
DMITROVSKY, ETHAN
|
DARTMOUTH COLLEGE
|
NH
|
$265,195
|
|
Hematology
|
2012
|
NCI
|
5R01CA139633-03
|
|
Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$634,757
|
|
Hematology
|
2012
|
NIAID
|
5R01AI027913-23
|
|
Bioactivities of Pneumococcal Cell Wall in Meningitis
|
TUOMANEN, ELAINE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$420,000
|
|
Hematology
|
2012
|
NIAID
|
5R01AI080759-04
|
|
Lymphopoietic development in the extra-embryonic yolk sac
|
YODER, MERVIN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$354,504
|
|
Hematology
|
2012
|
NCI
|
5R01CA129488-04
|
|
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
|
LAPPE, JOAN
|
CREIGHTON UNIVERSITY
|
NE
|
$744,389
|
|
Hematology
|
2012
|
NICHD
|
5U01HD049934-08
|
|
Data Coordinating Center for the Collaborative Pediatric Critical Care
|
DEAN, JONATHAN
|
UNIVERSITY OF UTAH
|
UT
|
$2,755,872
|
|
Hematology
|
2012
|
NIAID
|
5R01AI042254-14
|
|
Ikaros and Mi-2 beta interactions in early lymphoid development
|
GEORGOPOULOS, KATIA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$433,694
|
|
Hematology
|
2012
|
NCI
|
5R01CA127264-04
|
|
Cdk-2 Independent role of cyclin E in Cell survival
|
ALMASAN, ALEXANDRU
|
THE CLEVELAND CLINC FOUNDATION
|
OH
|
$315,543
|
|
Hematology
|
2012
|
NICHD
|
5U10HD049983-08
|
|
Collaborative Pediatric Critical Care Research Network At Children's Hospital of
|
CARCILLO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$267,005
|
|
Hematology
|
2012
|
NCI
|
5R01CA090668-10
|
|
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia
|
SMALL, DONALD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$284,804
|
|
Hematology
|
2012
|
NCI
|
5R01CA102142-08
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$330,937
|
|
Hematology
|
2012
|
NICHD
|
5U10HD063106-03
|
|
Collaborative Pediatric Research Critical Care Network(U10)
|
SHANLEY, THOMAS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$256,414
|
|
Hematology
|
2012
|
NCI
|
5R01CA134674-03
|
|
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
|
CAMP, NICOLA
|
UNIVERSITY OF UTAH
|
UT
|
$558,420
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL089176-04
|
|
Regulation of Monocyte and Granulocyte Lineage Specification
|
FRIEDMAN, ALAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,900
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL052246-18
|
|
Structure and Function of Protein C
|
GRIFFIN, JOHN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$702,913
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL064274-11
|
|
Hepatic Gene Transfer for Treatment of Hemophilias A & B
|
KAY, MARK
|
STANFORD UNIVERSITY
|
CA
|
$547,029
|
|
Hematology
|
2012
|
NIGMS
|
5K08GM083207-05
|
|
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis
|
FREDENBURGH, LAURA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$130,950
|
|
Hematology
|
2012
|
NHLBI
|
7R01HL098295-03
|
|
Computer-Assisted Hydrodynamic Gene Delivery for Hemophilia Gene Therapy
|
LIU, DEXI
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$515,393
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL094505-04
|
|
ER-to-Golgi transport of coagulation factors V and VIII
|
ZHANG, BIN
|
THE CLEVELAND CLINC FOUNDATION
|
OH
|
$353,250
|
|
Hematology
|
2012
|
NCI
|
5R01CA139389-03
|
|
Lymphoma Therapy with Reprogrammed Measles Viruses
|
CATTANEO, ROBERTO
|
MAYO CLINIC
|
MN
|
$304,127
|
|
Hematology
|
2012
|
NHLBI
|
5K08HL088126-05
|
|
Rac1 and Rac2 Guanosine Triphosphatases in Erythroid Function and Differentiation
|
KALFA, THEODOSIA
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
OH
|
$128,655
|
|
Hematology
|
2012
|
NHLBI
|
5K08HL088260-06
|
|
REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIAS
|
PILLAI, ASHA
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$130,599
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL090775-05
|
|
Role of cross-presentation by APCs in modulating graft-versus-leukemia responses
|
REDDY, PAVAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$371,626
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL031237-27
|
|
Monokine Gene Expression/Regulation in Lung Injury
|
KUNKEL, STEVEN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$373,215
|
|
Hematology
|
2012
|
NCI
|
5R01CA129826-03
|
|
Studies of the role of microRNA miR-16-1 in the NZB mouse model of CLL
|
RAVECHE, ELIZABETH
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$313,989
|
|
Hematology
|
2012
|
NCI
|
5R01CA136671-04
|
|
Comparative Pharmaco-oncogenomics of Myeloma Drug Resistance
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
AZ
|
$322,040
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL031823-23
|
|
Hematological consequences of FLVCR, a cytoplasmic heme export protein
|
ABKOWITZ, JANIS
|
UNIVERSITY OF WASHINGTON
|
WA
|
$390,000
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL106074-02
|
|
Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I
|
THOMAS, WENDY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$419,227
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL104165-02
|
|
Structure-function of cytoprotective coagulation proteases and their receptors
|
MOSNIER, LAURENT
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$473,750
|
|
Hematology
|
2012
|
NIGMS
|
5R01GM057692-13
|
|
Structural studies of a spectrin/ankyrin complex
|
MONDRAGON, ALFONSO
|
NORTHWESTERN UNIVERSITY
|
IL
|
$278,045
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL068212-09
|
|
Protein Tyrosine Phosphatase and Hematopoietic Cell Regulation
|
QU, CHENG-KUI
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$382,388
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL075735-09
|
|
Gfi-proteins in Hematopoietic Development
|
ORKIN, STUART
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$423,225
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL085707-04
|
|
RDSafe: A Multi-Institutional Study of HSC Donor Safety and Quality Life
|
PULSIPHER, MICHAEL
|
UNIVERSITY OF UTAH
|
UT
|
$598,019
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL087948-06
|
|
A model of myelodysplastic syndrome progression and leukemic stem cells
|
MA, YUPO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$413,624
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL098511-03
|
|
Molecular Pathogenesis of MDS and CMML
|
MACIEJEWSKI, JAROSLAW
|
THE CLEVELAND CLINC FOUNDATION
|
OH
|
$392,500
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL101382-03
|
|
Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Study
|
BENNETT-GUERRERO, ELLIOTT
|
DUKE UNIVERSITY
|
NC
|
$416,355
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL081111-04
|
|
Role of Vav and Rac in KIT oncogenesis
|
KAPUR, REUBEN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$381,150
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL087188-04
|
|
MLL in maintenance and regulation of HOX gene expression
|
ZELEZNIK-LE, NANCY
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$330,784
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL091724-19
|
|
Biochemistry of Leukemia Virus Core Binding Factor
|
SPECK, NANCY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$389,813
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL095896-03
|
|
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation
|
ZHANG, JIWANG
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$370,013
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL096305-03
|
|
Role of PGE2 and other eicosanoids in hematopoietic stem cell function
|
PELUS, LOUIS
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$381,150
|
|
Hematology
|
2012
|
NHLBI
|
5SC1HL104638-03
|
|
Genetic and Epigenetic Regulation of Hematopoiesis.
|
SALEQUE, SHIREEN
|
CITY COLLEGE OF NEW YORK
|
NY
|
$385,000
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL105631-02
|
|
Role of Fanconi Anemia Core Complex in the Incision of DNA Interstrand Crosslinks
|
ZHANG, YANBIN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$380,236
|
|
Hematology
|
2012
|
NCI
|
5R01CA129968-04
|
|
Arsenic-induced apoptosis in myeloma
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
GA
|
$362,855
|
|
Hematology
|
2012
|
NIAID
|
5R01AI073342-06
|
|
Molecular Detection of Blood Stream Infections in Women with Gynecologic Cancer
|
JORDAN, JEANNE
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$305,791
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL060772-12
|
|
ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
MO
|
$380,000
|
|
Hematology
|
2012
|
NCI
|
5R01CA096856-09
|
|
Novel role of STAT3 in NPM/ALK-induced oncogenesis
|
WASIK, MARIUSZ
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$290,381
|
|
Hematology
|
2012
|
NCI
|
5R01CA155743-02
|
|
The role of PHF6 in T-cell acute lymphoblastic leukemia
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$332,000
|
|
Hematology
|
2012
|
NIGMS
|
5R01GM086703-04
|
|
Chemical approaches for studying the biology of CD38
|
LIN, HENING
|
CORNELL UNIVERSITY
|
NY
|
$292,965
|
|
Hematology
|
2012
|
NCI
|
5R01CA136895-04
|
|
Molecular targets in diffuse large B cell lymphoma
|
DAVE, SANDEEP
|
DUKE UNIVERSITY
|
NC
|
$251,191
|
|
Hematology
|
2012
|
NHLBI
|
5R21HL102882-02
|
|
Soluble EPO Receptor and EPO Resistance in Dialysis
|
THADHANI, RAVI
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$175,500
|
|
Hematology
|
2012
|
NCI
|
5R01CA135053-04
|
|
Role of Dok-1 in oncogenic tyrosine kinase signaling
|
VAN AELST, LINDA
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$376,384
|
|
Hematology
|
2012
|
NCI
|
5R01CA155223-02
|
|
Mechanisms of Epigenetic Gene Silencing
|
PRUITT, KEVIN
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
LA
|
$268,920
|
|
Hematology
|
2012
|
NCI
|
5R01CA152101-03
|
|
Targeting Somatic Homologous Recombination in Solid Tumors
|
VILLALONA, MIGUEL
|
OHIO STATE UNIVERSITY
|
OH
|
$516,618
|
|
Hematology
|
2012
|
NCI
|
5R01CA138541-03
|
|
Myxoma Virus (MV) Oncolysis for treating human cancer
|
MCFADDEN, GRANT
|
UNIVERSITY OF FLORIDA
|
FL
|
$294,868
|
|
Hematology
|
2012
|
NCI
|
5R01CA138535-03
|
|
Novel Heparanase Inhibitors for Cancer Therapy
|
SANDERSON, RALPH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$403,257
|
|
Hematology
|
2012
|
NCI
|
5R01CA142809-03
|
|
Signal Transduction Pathways in CD30-positive Lymphomas
|
DUCKETT, COLIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$310,192
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL070047-08
|
|
Rheologic and Vascular Modulators in Sickle Vaso-occlusion
|
KAUL, DHANANJAY
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
NY
|
$373,500
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL092624-03
|
|
Role of hemoglobin b93cys residue in nitric oxide bioactivity
|
PATEL, RAKESH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$364,568
|
|
Hematology
|
2012
|
NIGMS
|
5R01GM046354-18
|
|
Differential Effects of Sepsis on Immune Cell Function
|
AYALA, ALFRED
|
RHODE ISLAND HOSPITAL
|
RI
|
$329,467
|
|
Hematology
|
2012
|
NCI
|
5R01CA089455-11
|
|
Dot 1 Complex, Transcriptional Elongation Control and Human Cancer
|
SHILATIFARD, ALI
|
STOWERS INSTITUTE FOR MEDICAL RESEARCH
|
MO
|
$256,294
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL089517-04
|
|
Calpain-1 Signaling Pathways in Platelets
|
CHISHTI, ATHAR
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$412,500
|
|
Hematology
|
2012
|
NIAID
|
5R01AI083663-03
|
|
Mucosal barrier function during Salmonella infection
|
RAFFATELLU, MANUELA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$368,870
|
|
Hematology
|
2012
|
NCI
|
5R01CA120512-05
|
|
CAK-RARa Signaling in HSC and Leukemic Cell Commitment to Differentiation
|
WU, LINGTAO
|
CHILDREN'S HOSPITAL LOS ANGELES
|
CA
|
$317,009
|
|
Hematology
|
2012
|
NCI
|
5R01CA142620-03
|
|
Immunologic targets in Myeloid Leukemia
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$330,091
|
|
Hematology
|
2012
|
NCI
|
5R01CA150265-03
|
|
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
|
SHILATIFARD, ALI
|
STOWERS INSTITUTE FOR MEDICAL RESEARCH
|
MO
|
$465,538
|
|
Hematology
|
2012
|
NCI
|
5R01CA139444-08
|
|
Integrin-targeted siRNA delivery for therapeutic gene silencing in blood cancers
|
SPRINGER, TIMOTHY
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$439,110
|
|
Hematology
|
2012
|
NCI
|
5R01CA133379-04
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$341,161
|
|
Hematology
|
2012
|
NIAID
|
5R01AI020069-29
|
|
Early Events in Mammalian B-Cell Differentiation
|
KINCADE, PAUL
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$399,391
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL098174-03
|
|
Septic Lung Injury and Surfactant
|
MALLAMPALLI, RAMA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$337,466
|
|
Hematology
|
2012
|
NIAID
|
5R01AI054928-09
|
|
Candida Invasion of Endothelium and Virulence
|
FILLER, SCOTT
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$274,950
|
|
Hematology
|
2012
|
NCI
|
5R01CA129330-04
|
|
Origin of CD5+ B cell Lymphoma/Leukemia in Mice
|
HAYAKAWA, KYOKO
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$351,225
|
|
Hematology
|
2012
|
NIGMS
|
5R01GM084244-04
|
|
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway
|
HUANG, TONY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$340,561
|
|
Hematology
|
2012
|
NCI
|
5R01CA129611-05
|
|
Development of JS-K as an anti-leukemic agent
|
SHAMI, PAUL
|
UNIVERSITY OF UTAH
|
UT
|
$302,919
|
|
Hematology
|
2012
|
NCI
|
5R01CA076287-14
|
|
Pretargeted Radioimmunotherapy of CD20+ Lymphomas
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$353,533
|
|
Hematology
|
2012
|
NINDS
|
5R01NS057670-03
|
|
The regulation of myeloid cell development and mobilization during autoimmune dem
|
SEGAL, BENJAMIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$255,739
|
|
Hematology
|
2012
|
NICHD
|
5R01HD062484-02
|
|
Pharmacogenetic Determinants of Vincristine Toxicity and Response
|
RENBARGER, JAMIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$621,364
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL057619-15
|
|
Gene Replacement Therapy for Sickle Cell Disease
|
TOWNES, TIM
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$431,044
|
|
Hematology
|
2012
|
NHLBI
|
5R21HL106421-02
|
|
Production of Bioactive NO: Origin of Hemoglobin E Associated Pathophysiology
|
FRIEDMAN, JOEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
NY
|
$207,500
|
|
Hematology
|
2012
|
NHLBI
|
5R21HL106451-02
|
|
Targeting the ROS-p38 MAPK Pathway as a Novel Strategy for Stem Cell Expansion
|
WANG, YONG
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$183,341
|
|
Hematology
|
2012
|
NCI
|
7R01CA140522-03
|
|
Molecular Mechanisms for the Assembly and Regulation of the MLL1 Core Complex
|
COSGROVE, MICHAEL
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$289,161
|
|
Hematology
|
2012
|
NCI
|
5R01CA148950-02
|
|
Regulation of Myc-Mediated Tumorigenesis
|
EISCHEN, CHRISTINE
|
VANDERBILT UNIVERSITY MED CTR
|
TN
|
$389,664
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL065217-10
|
|
Homocysteine & Heme: A Role in Thrombosis?
|
KRAUS, JAN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$370,435
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL074190-08
|
|
Pharmacogenetics of the human prostacyclin receptor.
|
HWA, JOHN
|
YALE UNIVERSITY
|
CT
|
$409,613
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL079904-14
|
|
Heme Oxygenase-1/Carbon Monoxide in sepsis
|
CHOI, AUGUSTINE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$418,775
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL090639-05
|
|
Estrogen, Platelets, and Artherosclerosis
|
MILLER, VIRGINIA
|
MAYO CLINIC
|
MN
|
$375,275
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL091020-05
|
|
Biophysical Analysis of GPIb-VWF Interaction
|
ZHU, CHENG
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
GA
|
$364,564
|
|
Hematology
|
2012
|
NCI
|
5R01CA129560-04
|
|
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas
|
HAQUE, AZIZUL
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$296,881
|
|
Hematology
|
2012
|
NIDDK
|
5R01DK083358-03
|
|
Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity
|
DROBYSKI, WILLIAM
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$312,246
|
|
Hematology
|
2012
|
NCI
|
5R01CA123204-04
|
|
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
|
LICHT, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$306,945
|
|
Hematology
|
2012
|
NCI
|
5R01CA123014-05
|
|
Genomic instability causes imatinib resistance in CML
|
SKORSKI, TOMASZ
|
TEMPLE UNIVERSITY
|
PA
|
$400,685
|
|
Hematology
|
2012
|
NCI
|
5R01CA096943-09
|
|
Leukemia Stem Cells: Essential Targets for GVL and Mediators of GVL-Resistance
|
SHLOMCHIK, WARREN
|
YALE UNIVERSITY
|
CT
|
$279,073
|
|
Hematology
|
2012
|
NCI
|
7R21CA155915-02
|
|
Bioactive compound modulation of epigenetic regulator Sp1/NFkB/miR network in AML
|
LIU, SHUJUN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$165,844
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL105613-02
|
|
Platelet Transfusion Induced Transplant Rejection Across mHA barriers.
|
ZIMRING, JAMES
|
EMORY UNIVERSITY
|
GA
|
$157,393
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL105809-02
|
|
Caring for Those Who Share: Mitigating Iron Deficiency in Regular Blood Donors
|
MAST, ALAN
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$786,228
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL095511-03
|
|
TCD with Transfusions Changing to Hydroxyurea - SDMC
|
DAVIS, BARRY
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$716,509
|
|
Hematology
|
2012
|
NCI
|
5R01CA085804-13
|
|
Bcl-2 function on the endoplasmic reticulum
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$284,448
|
|
Hematology
|
2012
|
NCI
|
5R01CA134573-04
|
|
The Role of the Stem Cell Niche in ALL
|
GIBSON, LAURA
|
WEST VIRGINIA UNIVERSITY
|
WV
|
$263,553
|
|
Hematology
|
2012
|
NHLBI
|
5F32HL104768-02
|
|
Improving fibrin-based bioartificial arteries by prolonging ERK activation
|
WEINBAUM, JUSTIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$55,670
|
|
Hematology
|
2012
|
NHLBI
|
5F30HL096396-03
|
|
An effort to create Factor IX expression vectors with sustained expression.
|
GRACEY, LIA
|
STANFORD UNIVERSITY
|
CA
|
$47,232
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL073015-08
|
|
Embryonic Stem Cells Induce Specific Graft Tolerance
|
ZAVAZAVA, NICHOLAS
|
UNIVERSITY OF IOWA
|
IA
|
$315,000
|
|
Hematology
|
2012
|
NCI
|
5R01CA139520-04
|
|
De-SUMOylation and the Hypoxic Response
|
YEH, EDWARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$309,964
|
|
Hematology
|
2012
|
NCI
|
5R01CA142665-03
|
|
Glucocorticoids in Lymphoblastic Leukemia
|
RELLING, MARY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$383,964
|
|
Hematology
|
2012
|
NCI
|
5R01CA138744-03
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$338,142
|
|
Hematology
|
2012
|
NHLBI
|
7R01HL082808-07
|
|
Structure and Function of Platelet Glycoprotein Ib-IX-V Complex
|
LI, RENHAO
|
EMORY UNIVERSITY
|
GA
|
$359,550
|
|
Hematology
|
2012
|
NCI
|
5R01CA142798-03
|
|
The contribution of protein translation to tumorigenesis
|
WENDEL, HANS-GUIDO
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$382,423
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL073328-10
|
|
Regulation of Protease-activated Receptor-1 Signaling
|
TREJO, JOANN
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$447,396
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL088010-05
|
|
Molecular Basis of Procofactor Activation
|
CAMIRE, RODNEY
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
PA
|
$325,710
|
|
Hematology
|
2012
|
NIMH
|
5R01MH085849-03
|
|
Risk for Psychopathology and Neurocognitive Impairment in Leukemia Survivors
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$498,542
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL089440-04
|
|
RIP2 Caspase-1 Signaling in Macrophages
|
WEWERS, MARK
|
OHIO STATE UNIVERSITY
|
OH
|
$371,250
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL098391-03
|
|
Smooth Muscle Cell Tissue Factor and Cardiovascular Disease
|
TAUBMAN, MARK
|
UNIVERSITY OF ROCHESTER
|
NY
|
$382,388
|
|
Hematology
|
2012
|
NIDDK
|
5R01DK055664-10
|
|
Hepatocyte Nitric Oxide Synthase Regulation by Glucagon and Insulin
|
HARBRECHT, BRIAN
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$308,241
|
|
Hematology
|
2012
|
NIAID
|
5R01AI041637-15
|
|
Cellular Activation Mechanisms in Septic Shock
|
TOBIAS, PETER
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$464,322
|
|
Hematology
|
2012
|
NIGMS
|
5F31GM090681-03
|
|
CD14: Biosynthesis, Trafficking and Secretion
|
NINO, DIEGO
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$31,865
|
|
Hematology
|
2012
|
NCI
|
5R01CA138747-03
|
|
microRNA-155 and Lymphoma
|
AGUIAR, RICARDO
|
UNIV OF TX HSC, SA
|
TX
|
$298,894
|
|
Hematology
|
2012
|
NCI
|
5R01CA129966-05
|
|
Antibody Neutralization of Therapeutic Viruses
|
RUSSELL, STEPHEN
|
MAYO CLINIC
|
MN
|
$488,632
|
|
Hematology
|
2012
|
NIGMS
|
5R01GM079707-04
|
|
Nonsense codon activation of endonuclease-mediated mRNA decay
|
SCHOENBERG, DANIEL
|
OHIO STATE UNIVERSITY
|
OH
|
$301,381
|
|
Hematology
|
2012
|
NCI
|
5R01CA129382-05
|
|
The role of AKT signaling in NOTCH1 induced leukemias
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$324,613
|
|
Hematology
|
2012
|
NCI
|
5R01CA143032-03
|
|
Molecular Targeting of Diffuse Large B-cell Lymphoma
|
MELNICK, ARI
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$571,087
|
|
Hematology
|
2012
|
NIDDK
|
5K08DK085152-03
|
|
Elucidation of Novel Anti-apoptotic Pathways in Erythropoiesis
|
WANG, YONGPING
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$2,042
|
|
Hematology
|
2012
|
NIDDK
|
5K01DK082982-04
|
|
MicroRNA Regulation of Stem Cell Self-renewal
|
GUO, SHANGQIN
|
YALE UNIVERSITY
|
CT
|
$153,657
|
|
Hematology
|
2012
|
NIDDK
|
5R01DK083164-04
|
|
Molecular Regulation of Erythroid Differentiation
|
CHEN, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$263,280
|
|
Hematology
|
2012
|
NINDS
|
5R01NS062792-04
|
|
The Mucolipin TRP Ion Channels
|
XU, HAOXING
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$325,030
|
|
Hematology
|
2012
|
NIGMS
|
5R01GM084447-04
|
|
Optimal Amino Acid Nutrition in Sepsis
|
DEUTZ, NICOLAAS
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
AR
|
$106,503
|
|
Hematology
|
2012
|
NCI
|
5R01CA151949-03
|
|
Molecular Pathogenesis and Therapy of ET and PMF
|
LEVINE, ROSS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$432,264
|
|
Hematology
|
2012
|
NIGMS
|
5SC3GM089564-03
|
|
Molecular mechanism of apolipoprotein binding to lipopolysaccharides
|
WEERS, PAUL
|
CALIFORNIA STATE UNIVERSITY LONG BEACH
|
CA
|
$106,549
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL106018-02
|
|
Site-specific therapies to prevent intimal hyperplasia
|
CHAIKOF, ELLIOT
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$398,000
|
|
Hematology
|
2012
|
NCI
|
5R01CA149976-02
|
|
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
|
SPECK, NANCY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$332,000
|
|
Hematology
|
2012
|
NCI
|
5R01CA154802-02
|
|
Approaches to discover and quantify apoptotic biomarkers for cancer treatment
|
WELLS, JAMES
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$320,588
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL106145-02
|
|
In vivo mechanism of mimetic peptide effects on atherosclerosis and inflammation
|
REARDON-ALULIS, CATHERINE
|
UNIVERSITY OF CHICAGO
|
IL
|
$390,000
|
|
Hematology
|
2012
|
NHLBI
|
5K08HL086868-05
|
|
Injured Lung and its Influence on Bone Marrow Cell Phenotype
|
ALIOTTA, JASON
|
RHODE ISLAND HOSPITAL
|
RI
|
$126,873
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL106184-02
|
|
Barrier Insulators in Erythropoiesis
|
GALLAGHER, PATRICK
|
YALE UNIVERSITY
|
CT
|
$414,375
|
|
Hematology
|
2012
|
FIC
|
5R03TW008753-02
|
|
Structural bases of ADAMTS-13 and VWF A2 interactions
|
ZHU, CHENG
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
GA
|
$55,564
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL056416-15
|
|
Mechanisms of Synergistic Regulation of Stem/Progenitors
|
BROXMEYER, HAL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$381,150
|
|
Hematology
|
2012
|
NHLBI
|
5K08HL105538-02
|
|
Pulmonary endothelial glycocalyx degradation causes ARDS during sepsis
|
SCHMIDT, ERIC
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$128,331
|
|
Hematology
|
2012
|
NHLBI
|
5F30HL099028-03
|
|
Maintenance of the Hematopoietic Stem Cell Niche Monocytes and Macrophages
|
CHOW, ANDREW
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$17,417
|
|
Hematology
|
2012
|
NCI
|
5R01CA142874-03
|
|
Targeting PML for leukemia therapy.
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$455,022
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL079571-08
|
|
A Vital Tool for the Study of DBA:The Diamond Blackfan Anemia Registry
|
LIPTON, JEFFREY
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$410,850
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL097971-03
|
|
Model of Platelet Adhesion and Thrombus Formation
|
KING, MICHAEL
|
CORNELL UNIVERSITY
|
NY
|
$393,081
|
|
Hematology
|
2012
|
NCI
|
5R01CA102774-08
|
|
A mouse model for human gastrointestinal stromal tumor
|
BESMER, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$390,130
|
|
Hematology
|
2012
|
NCI
|
5R01CA138398-03
|
|
C-reactive protein promotes myeloma cell-mediated bone destruction
|
YI, QING
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$357,767
|
|
Hematology
|
2012
|
NCI
|
5R01CA138720-03
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
PAGEL, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$354,244
|
|
Hematology
|
2012
|
NCI
|
5R01CA133881-03
|
|
Genetic Predictors of AML Treatment Response
|
APLENC, RICHARD
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
PA
|
$560,885
|
|
Hematology
|
2012
|
NCI
|
5R01CA055349-19
|
|
Biology of Alpha Particle Immunotherapy
|
SCHEINBERG, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$423,006
|
|
Hematology
|
2012
|
NHLBI
|
7R01HL097561-03
|
|
Molecular Pathogenesis of Diamond Blackfan Anemia
|
SAKAMOTO, KATHLEEN
|
STANFORD UNIVERSITY
|
CA
|
$463,934
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL061399-13
|
|
Regulation and Function of a Human Embryonic Globin
|
RUSSELL, J
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$389,813
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL095676-03
|
|
Regulation of Platelet Glycoprotein (GP) Ib-IX Complex Function by Membrane Lipid
|
PENG, YUANDONG
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$299,945
|
|
Hematology
|
2012
|
NCI
|
5R01CA100634-10
|
|
Radiovirotherapy for Multiple Myeloma
|
RUSSELL, STEPHEN
|
MAYO CLINIC
|
MN
|
$318,489
|
|
Hematology
|
2012
|
NCI
|
5R01CA141341-12
|
|
Rac GTPase-Specific Small Molecular Inhibitors
|
ZHENG, YI
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
OH
|
$242,044
|
|
Hematology
|
2012
|
NHLBI
|
5R21HL102618-02
|
|
Inhibition of Histone Deacetylase in Myeloproliferative Neoplasms
|
MOHI, GOLAM
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$199,375
|
|
Hematology
|
2012
|
NIDDK
|
5R01DK020503-32
|
|
Porphyrin biosynthesis in normal and disease states
|
PHILLIPS, JOHN
|
UNIVERSITY OF UTAH
|
UT
|
$320,824
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL095791-03
|
|
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
|
KEAN, LESLIE
|
EMORY UNIVERSITY
|
GA
|
$817,028
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL107127-02
|
|
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
|
KERR, WILLIAM
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$413,185
|
|
Hematology
|
2012
|
NHLBI
|
5R21HL102635-02
|
|
A novel mechanism of coagulation in sickle cell disease
|
BRITTAIN, JULIA
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$182,024
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL098489-03
|
|
Development of safe and efficient gene therapy strategies for hemoglobinopathies
|
KIEM, HANS-PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$704,283
|
|
Hematology
|
2012
|
NCI
|
5R01CA095274-09
|
|
Molecular Mechanisms of Leukemogenesis by PMLRAR alpha
|
KOGAN, SCOTT
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$286,137
|
|
Hematology
|
2012
|
NCI
|
5R01CA095512-09
|
|
Role of RNA Binding Proteins in BCR/ABL Leukemogenesis
|
PERROTTI, DANILO
|
OHIO STATE UNIVERSITY
|
OH
|
$243,296
|
|
Hematology
|
2012
|
NHLBI
|
1P50HL110789-01
|
|
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis
|
KULIOPULOS, ATHAN
|
TUFTS MEDICAL CENTER
|
MA
|
$2,159,793
|
|
Hematology
|
2012
|
NHLBI
|
1P50HL110787-01
|
|
Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell Transplant
|
DELANEY, COLLEEN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$2,670,621
|
|
Hematology
|
2012
|
NHLBI
|
1P50HL110790-01
|
|
A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia
|
NATHAN, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$2,282,414
|
|
Hematology
|
2012
|
NIAID
|
5R44AI065000-05
|
|
Bacterial-Induced Sepsis: A New Treatment Strategy
|
MCCOY, SHARON
|
13THERAPEUTICS, INC.
|
OR
|
$996,265
|
|
Hematology
|
2012
|
NIAID
|
5R01AI071028-05
|
|
Structure Function Analysis of Staphylococcal Complement Inhibitors
|
GEISBRECHT, BRIAN
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
MO
|
$300,401
|
|
Hematology
|
2012
|
NCI
|
5R01CA140515-03
|
|
Tyrosine Kinase Signaling in Cancer Cell Metabolism
|
CHEN, JING
|
EMORY UNIVERSITY
|
GA
|
$315,144
|
|
Hematology
|
2012
|
NCI
|
5R01CA127574-05
|
|
Cancer Stem Cell Targeting in Multiple Myeloma
|
MATSUI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$330,091
|
|
Hematology
|
2012
|
NCI
|
5R01CA083724-11
|
|
Chromosomal Abnormalities in Myeloma as Detected by FISH
|
FONSECA, RAFAEL
|
MAYO CLINIC ARIZONA
|
AZ
|
$320,288
|
|
Hematology
|
2012
|
NCI
|
5R01CA153260-13
|
|
Control of Lineage Commitment in Developing Thymocytes
|
KAPPES, DIETMAR
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$448,318
|
|
Hematology
|
2012
|
NCI
|
5R01CA097250-09
|
|
ROLE OF BETA 3 INTEGRIN IN SKELETAL METASTASIS
|
WEILBAECHER, KATHERINE
|
WASHINGTON UNIVERSITY
|
MO
|
$360,433
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL091957-04
|
|
Role of NOS2 in Sepsis-Induced ARDS
|
BARON, REBECCA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$436,689
|
|
Hematology
|
2012
|
NCI
|
5R01CA140575-03
|
|
Molecular pathogenesis of MLL-AF4 leukemias
|
ARMSTRONG, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$350,219
|
|
Hematology
|
2012
|
NHLBI
|
5R21HL097310-02
|
|
Ultrasound assisted thrombolysis for acute pulmonary embolism
|
SOLTANI, AZITA
|
EKOS CORPORATION
|
WA
|
$210,000
|
|
Hematology
|
2012
|
NCI
|
5R01CA137060-04
|
|
Pre-B cell receptor signaling in acute lymphoblastic leukemia
|
MUSCHEN, MARKUS
|
CHILDREN'S HOSPITAL LOS ANGELES
|
CA
|
$322,040
|
|
Hematology
|
2012
|
NINDS
|
5R01NS054651-05
|
|
Vascular Cognitive Impairment Induced by Ischemic Stroke: mechanism and therapy
|
YANG, SHAOHUA
|
UNIVERSITY OF TEXAS-DALLAS
|
TX
|
$308,700
|
|
Hematology
|
2012
|
NCI
|
5R01CA127621-04
|
|
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
|
ORNELLES, DAVID
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$409,936
|
|
Hematology
|
2012
|
NCI
|
5R01CA149655-03
|
|
Mechanisms of T cell leukemia induction and maintenance
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$340,155
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL083392-07
|
|
The role of pleckstrin & pleckstrin-2 in platelet biology.
|
ABRAMS, CHARLES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$407,878
|
|
Hematology
|
2012
|
NHLBI
|
5R37HL071544-10
|
|
Mechanism of Staphylocoagulase-activated Blood Clotting
|
BOCK, PAUL
|
VANDERBILT UNIVERSITY MED CTR
|
TN
|
$341,921
|
|
Hematology
|
2012
|
NHLBI
|
5R37HL044525-23
|
|
Molecular Interactions of Myeloid Cells with Endothelium
|
ZIMMERMAN, GUY
|
UNIVERSITY OF UTAH
|
UT
|
$372,263
|
|
Hematology
|
2012
|
NCI
|
5R01CA149442-03
|
|
Novel selective small-molecule inhibitors of Mcl-1 protein
|
NIKOLOVSKA-COLESKA, ZANETA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$310,210
|
|
Hematology
|
2012
|
NCI
|
5R01CA109663-08
|
|
CD45 Pretargeted Radioimmunotherapy for AML
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$293,447
|
|
Hematology
|
2012
|
NCI
|
5R01CA149668-03
|
|
Targeting apoptosis via chemical design of Bcl-2 antagonists
|
PELLECCHIA, MAURIZIO
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$384,435
|
|
Hematology
|
2012
|
NCI
|
5R01CA129036-05
|
|
Mechanisms of tumor resistance to anti-HER/ErbB therapeutics
|
FAN, ZHEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$309,964
|
|
Hematology
|
2012
|
NCI
|
5R01CA124952-05
|
|
4'-Substituted nucleoside analogs as anticancer drugs
|
SECRIST, JOHN
|
SOUTHERN RESEARCH INSTITUTE
|
AL
|
$441,240
|
|
Hematology
|
2012
|
NIAID
|
5R01AI056129-09
|
|
Notch-induced protein degradation in lymphopoiesis
|
SUN, XIAO-HONG
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$399,391
|
|
Hematology
|
2012
|
NCI
|
5R01CA138816-03
|
|
HES1 mediates cell-specific consequences of Notch signaling in ALL
|
ZWEIDLER-MCKAY, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$309,964
|
|
Hematology
|
2012
|
NCI
|
5R01CA100019-10
|
|
Clinical Significance of MHC Haplotypes in HCT
|
PETERSDORF, EFFIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$334,184
|
|
Hematology
|
2012
|
NCI
|
5R01CA124541-05
|
|
Role of miR155 in Leukemogenesis
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
OH
|
$301,148
|
|
Hematology
|
2012
|
NCI
|
5R01CA129528-05
|
|
Converting an Oncogene to an Apoptotic Factor by Manipulating Signal Sequences
|
LIM, CAROL
|
UNIVERSITY OF UTAH
|
UT
|
$275,034
|
|
Hematology
|
2012
|
NHLBI
|
5F30HL107092-02
|
|
Phagocyte Intoxication by ExoU in Pseudomonas Pneumonia
|
ZHANG, ANGELICA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$47,232
|
|
Hematology
|
2012
|
NHLBI
|
2T32HL007062-36
|
|
Hematology Research Training Program
|
VERCELLOTTI, GREGORY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$372,063
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL098316-03
|
|
The Fanconi anemia pathway: role in DNA interstrand cross-link repair
|
WALTER, JOHANNES
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$417,792
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL079669-07
|
|
Cell Priming, Receptor Cross-talk and Acute Lung Injury
|
FAN, JIE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$314,500
|
|
Hematology
|
2012
|
NHLBI
|
5R42HL087466-03
|
|
A Bioactive Prosthetic Vascular Graft
|
PHANEUF, MATTHEW
|
BIOSURFACES
|
MA
|
$369,422
|
|
Hematology
|
2012
|
NHLBI
|
5R01HL103427-02
|
|
Quality of Life After Treatment with Magnesium for Acute Sickle Cell Pain Episode
|
PANEPINTO, JULIE
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$316,226
|
|
Hematology
|
2012
|
NHLBI
|
5R34HL105776-02
|
|
Phase II Study of a Novel GVHD Prevention Strategy: Etanercept and Photopheresis
|
LEVINE, JOHN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$233,250
|
|
Hematology
|
2012
|
NCI
|
5R01CA144248-03
|
|
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
|
KLUG, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$294,868
|
|
Hematology
|
2012
|
NIDDK
|
5R01DK089174-02
|
|
Comparative Epidemiology for Emerging Glycemic Markers
|
SELVIN, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$568,059
|
|
Hematology
|
2012
|
NCI
|
5R01CA150547-03
|
|
Targeting Cdc42 in leukemia stem cells
|
ZHENG, YI
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
OH
|
$307,951
|
|
Hematology
|
2012
|
NCI
|
5R01CA102707-08
|
|
Inhibition of Cytochrome c-induced Caspase Activation
|
KORNBLUTH, SALLY
|
DUKE UNIVERSITY
|
NC
|
$263,055
|
|
Hematology
|
2012
|
NINDS
|
5R01NS070001-03
|
|
Novel Signaling Pathways in Ischemic Stroke
|
LIAO, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$382,659
|
|
Hematology
|
2012
|
NIAID
|
5R01AI023859-25
|
|
Role of CD14 and other innate immune receptors in severe sepsis
|
GOYERT, SANNA
|
CITY COLLEGE OF NEW YORK
|
NY
|
$377,339
|
|
Hematology
|
2012
|
NINDS
|
5R01NS038684-12
|
|
Cell Free O2 Carriers: Cerebrovascular Control and Stroke
|
KOEHLER, RAYMOND
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$351,575
|
|
Hematology
|
2012
|
NCI
|
5R01CA095684-09
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$310,971
|
|
Hematology
|
2012
|
NCI
|
5R01CA061508-18
|
|
Hematopoietic Progenitor Cells - Cord Blood
|
SHPALL, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$309,964
|
|
Hematology
|
2012
|
NHLBI
|
1T32HL110841-01
|
|
Children's Research Institute Hematology Research Training Grant
|
LUBAN, NAOMI
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$73,004
|
|
Hematology
|
2012
|
NIGMS
|
1SC3GM099632-01
|
|
Gut Circadian Clock and Melatonin Dynamics Following Major Thermal Injury
|
AL GHOUL, WALID
|
CHICAGO STATE UNIVERSITY
|
IL
|
$108,750
|
|
Hematology
|
2012
|
NHLBI
|
2T32HL007974-11
|
|
Immunohematology/Transfusion Medicine Research Training
|
SMITH, BRIAN
|
YALE UNIVERSITY
|
CT
|
$395,456
|
|
Hematology
|
2012
|
NHLBI
|
2T32HL007150-36
|
|
Pediatric Hematology Research Training Program
|
HIGH, KATHERINE
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
PA
|
$117,138
|
|
